New drug shows promise for rare swelling disease
NCT ID NCT04602598
First seen Apr 01, 2026 · Last updated May 13, 2026 · Updated 8 times
Summary
This study tested a drug called zanubrutinib in 10 adults with IgG4-related disease, a condition that causes swelling in glands like those under the jaw and around the eyes. The goal was to see if the drug could safely reduce gland size and inflammation. Participants took the medication for 24 weeks and had scans to measure changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IGG4-RELATED DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94304, United States
Conditions
Explore the condition pages connected to this study.